| 单词 | plasminogen activator | ||||||||||||||||
| 释义 | plasminogen activator
更多释义 收起释义 例句释义: 纤溶酶原激活物,纤溶酶原激活剂,胞浆素原活化剂 1. Conclusion The diabetic nephropathy patients have imbalance of plasma plasminogen activator and its inhibitor system. 结论：糖尿病肾病患者存在血浆纤溶酶原激活物及其抑制物系统失衡。 www.bing.com 2. abstract: Objective To investigate the plasminogen activator inhibitor changes in patients with diabetic nephropathy. 目的：探讨糖尿病肾病患者血浆纤溶酶原激活物抑制物的变化。 www.bing.com 3. Recombinant tissue-type plasminogen activator (r-TPA) was also used when clinically indicated. 临床上有指征时也可应用重组组织型纤溶酶原激活剂。 dictsearch.appspot.com 4. Cost-effectiveness of recombinant tissue plasminogen activator in the management of acute ischemic stroke: a systematic review. 急性缺血性卒中患应用重组组织纤溶酶原激活剂治疗的效用成本：一项系统性回顾 wenku.baidu.com 5. The abnormal activity of tissue-type plasminogen activator(t-PA) is the most risk factor of prethrombotic state of cardiovascular diseases. 组织型纤溶酶原激活物（tPA）活性异常是心血管疾病血栓前状态的最危险因素。 www.chemyq.com 6. abstract: Objective: To discuss the clinical value of detecting blood plasminogen activator and inhibitor in cancer patients. 目的：探讨恶性肿瘤患者血液纤溶酶原激活剂与抑制剂检测的临床应用价值。 www.bing.com 7. THE EXPRESSION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR IN ORAL SQUAMOUS CELL CARCINOMA. 尿激酶受体在口腔鳞癌中的表达。 www.ilib.cn 8. A drug called tissue plasminogen activator -- tPA -- dissolves clots and restores blood flow. 而一种称为组织纤维蛋白溶酶原激活物（tPA）的药物可以溶解血块，并恢复血液流通。 news.dxy.cn 9. The high-phenol group also experienced a greater drop in the activity of another clot promoter, plasminogen activator inhibitor-1. 高酚早餐组另一血栓促进因子——纤维蛋白溶酶原活化抑制因子-1的活性也呈现显著降低。 news.dxy.cn 10. Plasminogen activator inhibitor-1(PAI-1)is the main regulator of the fibrinolytic system. 血浆纤溶酶原激活物抑制剂（PAI）-1是纤溶系统的主要调控因子。 www.chemyq.com 1. Plasminogen activator inhibitor-1 (PAI-1) is a single strand glycoprotein, which can inhibit plasminogen activation. 纤溶酶原激活物抑制剂1（PAI-1）是一种单链糖蛋白，起抑制纤溶活性的作用。 www.chemyq.com 2. Because of extensive purpura fulminans with skin necrosis recombinant tissue plasminogen activator (rt-PA) was used. 由于广泛的暴发性紫癜皮肤坏死与重组组织型纤溶酶原激活剂（酶原激活剂）的使用。 www.syyxw.com 3. NIHSS scores were determined before tissue plasminogen activator bolus and at 60 and 120 minutes in both data sets. 在两个试验中，在组织纤维蛋白溶酶原激活剂使用前，都先用NIHSS评分。 www.med66.com 4. Expression and its significance of urokinase-type plasminogen activator system in a nasopharyngeal carcinoma cell line and two sub-lines 尿激酶型纤溶酶原激活剂系统在鼻咽癌细胞系及其两个克隆株中的表达和意义 www.ilib.cn 5. Study of Activity of Plasminogen Activator and Plasminogen Activator Inhibitor in Experimental Diabetic Rats with Cerebral Ischemia 实验性糖尿病大鼠脑缺血纤溶酶原激活物和纤溶酶原激活物抑制剂活性测定 www.ilib.cn 6. Effect of tissue-typed plasminogen activator on the adhesion of platelets on the surface of biomaterials 组织型纤溶酶原激活因子对生物材料表面血小板黏附的影响 www.ilib.cn 7. Effects of Chemical Modification on the Fibrinolytic Activity and Half-Life of Recombinant Tissue-Type Plasminogen Activator 化学修饰对组织型纤溶酶原激活剂的纤溶活性和体内半衰期的影响 www.ilib.cn 8. Dynamic Changes and Significance of Plasma Urokinase-Type Plasminogen Activator and its Receptor in Rats after Pulmonary Thromboembolism 肺血栓栓塞症大鼠血浆尿激酶型纤溶酶原激活物及其受体的动态变化及其意义 www.ilib.cn 9. Construction and Expression of a Recombinant Antibody-targeted Plasminogen Activator 一种导向性溶栓剂的基因构建及其在大肠杆菌中的表达 www.ilib.cn 10. Polymorphism of plasminogen activator inhibitor-1 gene in the children of elderly patients with type 2 diabetes mellitus 老年2型糖尿病患者子女纤溶酶原激活物抑制物1基因的多态性 www.ilib.cn 1. Intravenous thrombolysis therapies in acute myocardial infarction with the reconstructive tissue plasminogen activator in prehospital care 急性心肌梗死院前应用重组组织型纤溶酶原激活剂溶栓研究 www.ilib.cn 2. Expression of urokinase-type plasminogen activator receptor and its significance in laryngeal squamous cell carcinoma 尿激酶型纤溶酶原激活剂受体在喉鳞癌中的表达及意义 service.ilib.cn 3. The relation between the expression of urokinase-type plasminogen activator receptor and clinical pathologic grade in human brain glioma 人脑胶质瘤中尿激酶型纤溶酶原激活物受体的表达与临床病理分级的关系 service.ilib.cn 4. Clinical Thrombolytic Trial of A New Type of Tissue-Plasminogen Activator in Patients with Acute Myocardial Infarction 一种新的人组织纤溶酶原激活剂对急性心肌梗死的溶栓效果 168.160.184.78 5. Study on the Expression of Urokinase-type Plasminogen Activator Receptor in Thrombotic Patients and its Clinical Implications 尿激酶受体在血栓性疾病中的表达及临床意义 www.ilib.cn 6. Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis 骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达 www.ilib.cn 7. Expression of Urokinase-type Plasminogen Activator Receptor in Epithelial Ovarian Cancer and its Significance 尿激酶型纤溶酶原激活物受体在上皮性卵巢癌中的表达及其意义 www.ilib.cn 8. Clinical Significance of Measurement of Plasma Urokinase Type Plasminogen Activator and its Receptor in Cancer Patients 癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义 www.ilib.cn 9. Discussion for the Problems in Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction 急性脑梗死静脉溶栓治疗的难点与对策 www.ilib.cn 10. Prognostic value of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx 尿激酶型纤溶酶原激活剂及其抑制剂在喉癌患者预后中的价值 168.160.184.82:8080 1. Detection of Plasminogen activator and thrombomodulin in lung cancer patients and its clinical significance 肺癌患者纤溶酶原激活物和血栓调节蛋白检测分析 www.ilib.cn 2. Relationship between the Changes of Activity of Tissue-Type Plasminogen Activator on Brains and Cerebral Edema in Asphyxia Status of Mice 窒息鼠脑组织型纤溶酶原激活物活性变化与脑水肿的关系 www.ilib.cn 3. The change of plasma urokinase-type plasminogen activator and its receptor in patients with intracerebral hemorrhage 脑出血患者尿激酶型纤溶酶原激活物及其受体的变化 www.ilib.cn 4. Expression of urokinase - type plasminogen activator and its receptor in plasma of patients with cerebral infarction 急性脑梗死患者血浆尿激酶型纤溶酶原激活物及其受体的表达 www.ilib.cn 5. Construction of plasminogen activator and its expressive activity in human umbilical vein endothelial cell 组织型纤溶酶原激活因子构建及其在人脐静脉内皮细胞的表达活性 www.ilib.cn 6. Expression of Urokinase-type Plasminogen Activator and its Receptor in Hepatocellular Carcinoma 肝细胞癌尿激酶型纤溶酶原激活物及其受体的表达 www.ilib.cn 7. Plasma levels of soluble urokinase-type plasminogen activator receptor in lung cancer and its clinical significance 肺癌患者血浆尿激酶受体的检测及其临床意义 www.ilib.cn 8. Membrane and cytoplasmic expression of urokinase-type plasminogen activator receptor in synovial tissues of rheumatoid arthritis patients 尿激酶型纤溶酶原激活物受体在类风湿关节炎滑膜组织细胞的表达 www.ilib.cn 9. Comparison of thrombolytic therapy with recombinant tissue plasminogen activator and urokinase for acute myocardial infarction 尿激酶与重组织型纤溶酶原激活剂静脉溶栓治疗急性心肌梗死 www.ilib.cn 10. Expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in medulloblastomas 尿激酶型纤溶酶原激活剂及其受体在髓母细胞瘤中的表达研究 www.ilib.cn 1. Clinical study of urokinase-type plasminogen activator in mammary cancer and axillary lymph node 尿激酶型纤溶酶原激活剂在乳腺癌及腋窝淋巴结组织中的表达及其临床意义 scholar.ilib.cn 2. Detection and significance of urokinase-type plasminogen activator and its receptor in plasma in liver cirrhosis 肝硬化患者尿激酶型纤溶酶原激活物及其受体测定的临床意义 service.ilib.cn 3. The relationship between the number of metabolic syndrome components and the plasma levels of plasminogen activator inhibitor-1 代谢综合征组成成分数与血浆纤溶酶原激活物抑制因子-1水平的关系 service.ilib.cn 4. The expression of urokinase-type plasminogen activator and its specific receptor in neuroblastoma 尿激酶型纤溶酶原激活因子及其受体在神经母细胞瘤中的表达及其意义 www.ilib.cn 5. Effects of recombinant adenoviruses carrying human urokinase-type plasminogen activator on experimental liver fibrosis 人尿激酶型纤溶酶原激活物重组腺病毒对大鼠肝纤维化的影响 scholar.ilib.cn 6. Immunoblotting analysis of recombinant human glycosylated urinary type plasminogen activator in pilot-scale production 重组人糖基化尿型纤溶酶原激活剂中试产品抗原特异性的分析 www.ilib.cn 7. Clinical significance of measuring soluble urokinase-type plasminogen activator receptor in cancerous pleural effusion 肿瘤患者胸水可溶性尿激酶受体检测及其临床意义 www.ilib.cn 8. Clinical study on the expression of urokinase plasminogen activator and urokinase plasminogen activator receptor in pancreatic cancer 尿激酶型纤溶酶原激活剂及其受体在胰腺癌中表达的意义 168.160.184.78 9. The efficacy of thrombolysis with recombinant tissue plasminogen activator as compared with urokinase for acute myocardial infarction 重组组织型纤溶酶原激活剂和尿激酶治疗急性心肌梗死的疗效比较 scholar.ilib.cn 10. Urokinase plasminogen activator receptor and tissue factor expression in cholangiocarcinoma 组织因子、尿激酶型纤溶酶原激活剂受体在胆管癌表达的临床意义 service.ilib.cn 1. Expression and Clinical Significance of Urokinase-type Plasminogen Activator in Nasopharyngeal Carcinoma 尿激酶型纤溶酶原激活物在鼻咽癌的表达及临床意义 www.ilib.cn 2. Correlation between the occurrence of vascular dementia and the activity of tissue type plasminogen activator 血管性痴呆发生与组织型纤溶酶原激活物活性的相关性 www.ilib.cn 3. Combined intravenous and intra-arterial infusion of recombinant tissue plasminogen activator for treatment of acute ischemic stroke 重组组织型纤溶酶原激活剂动静脉联合溶栓治疗急性缺血性卒中 www.ilib.cn 4. Observation of therapeutic effect of recombinant tissue-type plasminogen activator venous embolism for acute myocardial infarction 重组组织型纤溶酶原激活剂静脉溶栓治疗急性心肌梗死的疗效观察 www.ilib.cn 5. Application of plasminogen activator to treating severe intraventricular hemorrhage 纤溶酶元激活剂在重度脑室内出血治疗中的应用 www.ilib.cn 6. Expression of urokinase-type plasminogen activator and its receptor in osteosarcoma 骨肉瘤中尿激酶型纤溶酶原激活因子和受体的表达 www.ilib.cn 7. Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients 慢性阻塞性肺疾病患者气道尿激酶型纤溶酶原激活物系统成分的高水平状态 www.ilib.cn 8. Clinical study of urokinase-type plasminogen activator mRNA in ovarian cancer 尿激酶型纤溶酶原激活剂mRNA在卵巢癌组织中的表达及其意义 www.ilib.cn 9. Therapeutic effect of recombinant urokinase-type plasminogen activator on experimental pulmonary embolism 重组尿激酶型纤溶酶原激活物治疗大鼠实验性肺血栓栓塞症的探讨 www.ilib.cn 10. Cloning, Expression and Identification of Activity of Recombinant Tissue- type Plasminogen Activator Mutant 重组人组织型纤溶酶原激活剂突变体基因的克隆、表达与生物活性鉴定 service.ilib.cn 1. Recombinant plasminogen activator Angiographic Phase II International Dose-finding study 血管造影期II国际重组纤溶酶原激活剂剂量探索研究 www.sinoas.com 2. The changes of the activities of tissue-type plasminogen activator of hypoxia-ischemia brain damage in perinatal periods 围生期缺氧缺血后脑组织型纤溶酶原激活物的活性变化 www.ilib.cn 3. Comparison of recombinant tissue - type plasminogen activator and urokinase in acute myocardial infarction 重组型纤溶酶原激活剂与尿激酶在急性心肌梗死溶栓中的比较 www.ilib.cn 4. Recombinant tissue plasminogen activator for treatment of fibrinous membranes after cataract surgery 重组组织型纤维蛋白酶原激活剂治疗白内障手术后的纤维蛋白膜 www.ilib.cn 5. Changes of Tissue-type Plasminogen Activator and Plasminogen Activator Inhibitor Activity in Plasma of Asphyxial Fetal Mice Embryo 窒息胎鼠血浆组织型纤溶酶原激活剂及其抑制物的变化 service.ilib.cn 6. Characterization and Pilot Production of Recombinant Human Urinary-type Plasminogen Activator 重组人尿型纤溶酶原激活剂的中试生产与性质研究 168.160.184.78 7. The Effects of Urokinase Plasminogen Activator Articular Injected Intra-articular on Articular Cartilage 关节内注射尿激酶型纤溶酶原激活物对关节软骨的实验研究 www.ilib.cn 8. Expression and Significance of Urokinase-type Plasminogen Activator in Medulloblastoma 尿激酶型纤溶酶原激活剂在髓母细胞瘤中的表达及意义 www.ilib.cn 9. Role of type I plasminogen activator inhibitor in mediating renal tubulointerstitial injury of patients with IgA nephropathy 型纤溶酶原激活物抑制物在IgA肾病肾小管间质损伤中的作用研究 www.wanfangdata.com.cn 10. The mechanism of the regulation of calcium to the expression of tissue plasminogen activator in epidermis 表皮细胞中钙离子调节组织型纤溶酶原激活剂表达的机制 www.ilib.cn 1. Association between Genetic Polymorphisms of Type I Plasminogen Activator Inhibitor and Ischemic Stroke 血浆I型纤溶酶原激活物抑制剂基因多态性与缺血性脑卒中的关系 www.ilib.cn 2. Expression and Significance of Urokinase - type Plasminogen Activator in Glioblastoma 尿激酶型纤溶酶原激活剂在胶质母细胞瘤中表达及意义 www.ilib.cn 3. Fluid shear stress regulates secretion of tissue-type plasminogen activator in human endothelial progenitor cells 流体切应力调节内皮祖细胞分泌组织纤溶酶原激活物的研究 www.ilib.cn 4. Expression of urokinase-type plasminogen activator receptor in medulloblastomas of children 儿童髓母细胞瘤中尿激酶型纤溶酶原激活剂受体表达 service.ilib.cn 5. Effect of Tissue-type Plasminogen Activator on Differentiation of Keratinocyte in the Human Embryonic Epiderm 组织型纤溶酶原激活剂在人胚胎表皮角质形成细胞分化中的作用 service.ilib.cn 6. Relationship between the gene polymorphism of plasminogen activator inhibitor-1 and coronary heart disease 纤溶酶原激活物抑制剂-1基因多态性与冠心病的关系 service.ilib.cn 7. Thrombolysis With Tissue Plasminogen Activator Alters Adhesion Molecule Expression in the Ischemic Rat Brain 组织纤溶酶原激活物溶栓治疗缺血性卒中大鼠导致大脑中粘附分子表达改变-评论 www.bhli.org.cn 8. Treating acute myocardial infarct with recombinant tissue-type plasminogen activator 重组组织型纤溶酶原激活药治疗急性心肌梗死 service.ilib.cn 9. congenital abnormalities of plasminogen activator release 先天性纤溶酶原激活物释放异常症 zhidao.baidu.com 10. Construction and in vitro Expression of Human Tissue-type Plasminogen Activator Gene Recombinant Eukaryotic Expression Vector 组织型纤溶酶原激活因子基因真核表达质粒的构建及其体外表达研究 168.160.184.82:8080 1. Urokinase-type Plasminogen Activator Improves the Reproductive Function of Male Rats 尿激酶型纤溶酶原激活因子对雄性大鼠生育力影响的实验研究 www.ilib.cn 2. Variation and clinical significance of urokinase-type plasminogen activator system in mammary cancer 乳腺癌患者血浆尿激酶型纤溶酶原激活系统的变化及其意义 168.160.184.78 3. Study on Role of the Plasminogen Activator in the Pathogenesis of Acute Pulmonary Thromboembolism 纤溶酶原激活物在肺血栓栓塞症发病机制中的作用 www.ilib.cn 4. Expressions and Significances of Urokinase-type Plasminogen Activator and its Receptor in Human Gliomas 尿激酶型纤溶酶原激活因子及其受体在人脑胶质瘤中的表达和意义 168.160.184.78 5. The relationship between urokinase plasminogen activator system and non-Hodgkin lymphoma 非霍奇金淋巴瘤外周血尿激酶型纤溶酶原激活物及其受体测定的临床意义 www.ilib.cn 6. Effect of Disc Displacement on mRNA Expression of Urokinase Plasminogen Activator and Its Inhibitor-1in Synovial Tissues 关节盘前移位对关节滑膜尿激酶型纤溶酶原激活剂及其1型抑制剂mRNA表达的影响 www.ilib.cn 7. European Cooperative Study Group for recombinant tissue-type plasminogen activator 欧洲合作研究组重组组织型纤溶酶原激活剂研究 www.sinoas.com 8. The effect of butyrate on the expression of urokinase plasminogen activator and its receptor in human colon cancer cells 丁酸对人结肠癌细胞尿激酶型纤溶酶原激活剂及受体表达的影响 www.ilib.cn 9. The Effects of Homocysteine on Endothelial Cell Secreting Tissue-Type Plasminogen Activator and its Inhibitor-1 同型半胱氨酸对内皮细胞分泌组织型纤溶酶原激活物及其抑制剂-1的影响 www.ilib.cn 10. Construction of tissue plasminogen activator eukaryotic expression vector and its expression in MCF-7 cell line 组织型纤溶酶原激活剂真核表达载体的构建及其在乳癌细胞系MCF-7中的瞬时表达 www.ilib.cn 1. The current status and progress of recombinant tissue plasminogen activator for treatment of ischemic stroke 重组组织型纤溶酶原激活剂治疗缺血性卒中的现状与进展 service.ilib.cn 2. Effect of mild hypothermia on the content of tissue-type plasminogen activator in retina tissue of rats with ischemia-reperfusion injury 亚低温对缺血再灌注损伤大鼠视网膜组织型纤溶酶原激活物含量的影响 www.ilib.cn 3. Inhibition of Cultured Human Retinal Pigment Epithelial Cell by Tissue-type Plasminogen Activator 组织型纤溶酶原激活剂对人视网膜色素上皮细胞的抑制 168.160.184.82:8080 4. Peptide mapping of recombinant human urinary-type plasminogen activator in pilot-scale production 重组人尿型纤溶酶原激活剂中试产品的肽图分析 www.ilib.cn 5. Recovery of blood-nerve barrier is delayed in tissue plasminogen activator gene knockout mice after sciatic nerve crush 组织型纤溶酶原激活剂促进小鼠坐骨神经血-神经屏障损伤后的修复 ilib.cn 6. Vitrectomy combined with tissue plasminogen activator and fraxiparine for fibrin exudation caused by bacterial endophthalmitis in rabbits 玻璃体切割术联合组织型纤溶酶原激活物和速避凝治疗兔细菌性眼内炎所致纤维蛋白渗出 www.ilib.cn 7. Regulation of tissue plasminogen activator expression by EGF in epidermal keratinocytes of mouse EGF对小鼠角质形成细胞中组织型纤溶酶原激活剂表达的调节 service.ilib.cn 8. Study on thrombolysis of a new recombinant ant ibody-targeted plasminogen activator in vitro 一种新型重组抗体导向溶栓剂的体外溶栓研究 www.ilib.cn 9. Effect of Jiangzhiningxuejian on hemorheology and plasma plasminogen activator and inhibitor in patients with hyperlipidemia 降脂宁血煎对高脂血症患者血液流变学及血浆纤溶酶原激活物、抑制物的影响 www.ilib.cn 10. The relation of plasma plasminogen activator inhibitor activity and coronary heart disease 纤溶酶原激活抑制物活性与冠心病发病关系 www.ilib.cn 1. Study on expression of plasminogen activator inhibitor type-1 and its correlation with cholesterolemia in the atherosclerotic rabbits 动脉粥样硬化兔纤溶酶原激活物抑制物-1的表达及与血脂相关性的研究 www.ilib.cn 2. Expression of urokiase-type plasminogen activator and matrix metalloproteinases in human tissue of abdominal aortic aneurysm 尿激酶型纤溶酶原活化物和基质金属蛋白酶类在腹主动脉瘤组织中的表达 www.ilib.cn 3. How Chronic Prostatitis Affects Plasminogen Activator System 慢性前列腺炎对纤溶酶原激活因子系统影响的初步研究 www.ilib.cn 4. Plasminogen activator and its assay of the activity 纤溶酶原激活剂及其活性测定 www.ilib.cn 5. The relationship between insulin resistance and plasminogen activator inhibitor type-1 in patients with cerebral infarction 脑梗死患者胰岛素抵抗与血浆纤溶酶原激活物抑制物-1的关系 www.ilib.cn 6. Clinical analysis of treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator: report on 23 cases 重组组织型纤溶酶原激活剂静脉溶栓治疗急性心肌梗死23例临床分析 service.ilib.cn 7. Expression and significance of urokinase-type plasminogen activator gene in human glioma 人脑胶质瘤尿激酶型纤溶酶原激活因子基因表达及意义 www.ilib.cn 8. The Correlation between Coronary Heart Disease and Hyperinsulinemia the Plasma Plasminogen Activator Inhibitor-1 高胰岛素血症、纤溶酶原激活物抑制物1与冠心病关系的初步研究 www.ilib.cn 9. The mechanism-exploring of fatty acids influencing plasminogen activator inhibitor -1 expression in endothelial cells 脂肪酸影响血管内皮细胞纤溶酶原激活物抑制剂-1表达的机制初探 www.ilib.cn 10. Relationship Between Plasminogen Activator Inhibitor-1 Gene and Coronary Heart Disease with Blood-stagnation Syndrome 冠心病心血瘀阻证与血液纤溶酶原激活物抑制剂-1基因的关系 www.ilib.cn 1. Effects of urokinase-type plasminogen activator on articular cartilage damage 关节软骨破坏与尿激酶型纤溶酶原激活物的影响 www.ilib.cn 2. Expressing of urokinase-type plasminogen activator in human glioma and correlated follow-up study 尿激酶型纤溶酶原激活物在人脑胶质瘤的表达与随访分析 www.ilib.cn 3. Clinical effect of intravenous infusion of recombinant tissue-type plasminogen activator in 20 patients with acute myocardial infarction 重组组织型纤溶酶原激活剂静脉溶栓治疗急性心肌梗死20例分析 www.ilib.cn 4. Detection of Residual Cell DNA from Recombinant Human Tissue-Type Plasminogen Activator 重组人组织型纤溶酶原激活剂中细胞残余DNA的检测 www.ilib.cn 5. Biosynthesis of Tissue-Type Plasminogen Activator Using Resting Cell Culture 用静息细胞培养法研究影响组织型纤溶酶原激活剂生物合成的因素 www.ilib.cn 6. Plasminogen activator combined with brain hemorrhage in vein thrombolysis with acute myocardial infarction-1 case report 纤溶酶原激活剂静脉溶栓治疗急性心肌梗死并发脑出血1例 www.ilib.cn 7. Expression of urokinase type plasminogen activator gene in patients with brain gliomas 脑胶质瘤患者尿激酶型纤溶酶原激活因子基因的表达 www.ilib.cn 8. The Expression of Urokinase-type Plasminogen Activator in Oral Squamous Cell Carcinoma 尿激酶型纤溶酶原激活物在口腔鳞癌中的表达及意义 www.ilib.cn 9. Expression of Tissue-type Plasminogen Activator and Its Inhibitor-1 in Acute Rat Spinal Cord Injuries 纤溶酶原激活剂及其抑制因子1在大鼠脊髓急性损伤时的表达 www.ilib.cn 10. Transient expression of tissue-type plasminogen activator in mammary gland tissues of mice 小鼠乳腺组织中组织型纤溶酶原激活剂乳腺特异性表达载体的瞬时表达 www.ilib.cn 1. Effect of contact system in monocyte adhesion induced by urokinase-type plasminogen activator 内源性接触激活系统对单核细胞粘附的影响 www.ilib.cn 2. Changes of plasminogen activator inhibitor-1 activity and effects of exogenous urokinase on endotoxin-induced acute lung injury 急性肺损伤时纤溶酶原激活物抑制剂-1活性变化和尿激酶对其变化的影响 www.ilib.cn 3. The regulatory effect of tissue plasminogen activator involved in central nervous insult 组织型纤溶酶原激活物在中枢神经损伤中的调节作用 www.ilib.cn 4. Influences on the activities of tissue- type plasminogen activator of mouse brain in asphyxia 窒息对鼠脑分泌组织型纤溶酶原激活物的影响 www.ilib.cn 5. Interrelation between plasminogen activator inhibitor 1, insulin resistance and the extent of coronary artery disease 血浆纤溶酶原激活物抑制物1、胰岛素抵抗与冠状动脉病变程度的关系 www.ilib.cn 6. The relationship between insulin resistance and plasminogen activator inhibitor type-1 in the elderly of coronary heart disease 老年冠心病患者胰岛素抵抗与血浆纤溶酶原激活物抑制物-1的关系 www.ilib.cn 7. Nursing care of patients with acute myocardial infarction treated with recombinant human tissue plasminogen activator 重组人组织纤溶酶原激活剂治疗急性心肌梗死病人的护理 www.ilib.cn 8. Study on the Expression of Urokinase-type Plasminogen Activator in Renal Cell Carcinoma 肾细胞癌尿激酶型纤溶酶原激活物表达的研究 www.ilib.cn 9. Expression of tissue plasminogen activator and inhibitor-1 after acute pulmonary thromboembolism in rabbit 肺血栓栓塞后组织型纤溶酶原激活物及其抑制物-1在肺动脉中的表达 www.ilib.cn 10. The Expression of Urokinase-type Plasminogen Activator Receptor in Lung Cancer 尿激酶受体在肺癌组织中的表达 www.ilib.cn 1. Effects of tissue- type plasminogen activator gene therapy on restenosis of vein grafts 组织型纤溶酶原激活因子基因对移植静脉再狭窄的影响 www.ilib.cn 2. Recombinant tissue-type plasminogen activator treat acute myocardial infarction for 46 patients 重组组织型纤溶酶原激活剂治疗急性心肌梗死46例 service.ilib.cn 3. Effect of Intrauterine Asphyxia on Expression of Tissue-Type Plasminogen Activator in Fetal Rat's Brain 宫内窒息对胎鼠脑组织型纤溶酶原激活物表达的影响 www.ilib.cn 4. Cloning and identification of human tissue-type plasminogen activator gene 人组织型纤溶蛋白酶原激活剂基因的克隆与鉴定 www.ilib.cn 5. Effect of ligustrazine on tissue-type plasminogen activator in the retina of rats with diabetes mellitus 川芎嗪对糖尿病大鼠视网膜组织型纤溶酶原激活物含量的影响 www.ilib.cn 6. Effect of High Glucose on the Expression of Fibronectin and Plasminogen Activator Inhibitor-1 in Human Peritoneal Mesothelial Cells 高糖对人腹膜间皮细胞纤维连接蛋白及纤溶酶原激活物抑制剂-1的影响 www.ilib.cn 7. The effect of recombinant human tissue plasminogen activator on coagulation function and immune response in pigs 重组人类组织型纤溶酶原激活剂对家猪凝血和免疫指标的影响 www.ilib.cn 8. Effects of advanced glycation end products on the expression of plasminogen activator inhibitor- 1 in rat mesangial cells 糖基化终末产物对大鼠肾系膜细胞纤溶酶原激活物抑制物-1表达的影响 www.ilib.cn 9. Expression of urokinase-type plasminogen activator in human glioma 尿激酶型纤溶酶原激活剂在人脑胶质瘤中的表达 www.ilib.cn 10. The Study of Expression of Recombinant Human Tissue-Type Plasminogen Activator Derivative in E. Coli 重组人组织型纤溶酶原激活物衍生物在大肠杆菌中表达的研究 www.ilib.cn 1. Expression of urokinase-type plasminogen activator in non-small cell lung cancer 尿激酶型纤溶酶原激活物在非小细胞肺癌组织中的表达 www.ilib.cn 2. The Effect of Urokinase Plasminogen Activator on Proteoglycan in Articular Cartilage Matrix 尿激酶型纤溶酶原激活物对关节软骨蛋白多糖的影响 www.ilib.cn 3. Changes of matrix metalloproteinase -3 and urokinase -type plasminogen activator receptor in type 2 diabetes mellitus with macroangiopathy 基质金属蛋白酶3和尿激酶型纤溶酶原激活物受体在2型糖尿病大血管病变中的变化 www.ilib.cn 4. Influence of fatty acids on expression of plasminogen activator inhibitor-1 in human vascular endothelial cells 脂肪酸对人血管内皮细胞纤溶酶原激活物抑制剂-1表达的影响 www.ilib.cn 5. The expression of urokinase-type plasminogen activator in the hair follicle 尿激酶型纤溶酶原激活物在毛囊中的表达 www.ilib.cn 6. Cytokine-induced release of plasminogen activator inhibitor-1 by human pleural mesothelial cells 细胞因子诱导人胸膜细胞释放纤溶酶原激活物抑制剂-1的研究 www.ilib.cn 7. Expression of plasminogen activator in human bladder cancer 纤溶酶原激活物在膀胱移行细胞癌中的表达及其意义 www.ilib.cn 8. Study on relationship of plasminogen activator inhibitor -1 and atherosclerosis in rabbits 纤溶酶原激活物抑制物-1与动脉粥样硬化关系的研究 www.ilib.cn 9. Recombinant human tissue-type plasminogen activator, rt-PA 重组人组织纤溶酶原激活剂 www.cjebm.org.cn 10. The Influence of Antisense Plasminogen Activator Inhibitor-1 RNA on Atherosclerosis in Rabbits 反义纤溶酶原激活物抑制剂1RNA对家兔动脉粥样硬化形成的影响 www.ilib.cn 1. The Progress of the Study on the Relationship between Urokinase-Type Plasminogen Activator and Osteoarthritis 尿激酶型纤溶酶原激活物与骨性关节炎研究进展 www.ilib.cn 2. Effect of Intrahematomally Using Plasminogen Activator on the Perihematomal Brain Tissue after Intracerebral Hemorrhage in Rats 脑出血后血肿腔内应用纤溶酶原激活剂对血肿周围脑组织的影响 www.ilib.cn 3. R-TPA recombinant tissue plasminogen activator 重组的组织型纤溶酶原激活物 blog.bioon.com 4. Construction of human tissue plasminogen activator minigene 人组织型纤溶酶原激活剂突变体微小基因的构建 www.ilib.cn 5. The Study of Relationship between Tissue Plasminogen Activator and Diseases Related to Thrombus 组织型纤溶酶原激活物与血栓相关性疾病的关系研究 www.ilib.cn 6. Effect of different short-term intensive treatment methods on plasminogen activator inhibitor-1 in newly diagnosed type 2 diabetic patients 探讨纤溶酶原激活物抑制因子-1水平对评价2型糖尿病短期强化治疗疗效的临床意义 www.ilib.cn 7. Expression of Plasminogen Activator Inhibitor- 1 of Frozen Muscle Specimensin Muscular Dystrophy 肌营养不良冷冻肌肉标本纤溶酶原激活物抑制物-1的表达 www.ilib.cn 8. Advances of research in plasminogen activator inhibitor-1 纤溶酶原激活剂抑制物-1的研究进展 www.ilib.cn 9. Role of plasminogen activator inhibitor-1 in hepatic fibrosis 纤溶酶原激活物抑制剂-1在肝纤维化中的作用 www.ilib.cn 10. Effect of Pioglitazone on Plasminogen Activator Inhibitor-1 of Plasma in Type 2 Diabetic Mellitus Patients 吡格列酮对2型糖尿病患者血浆纤溶酶原激活物抑制剂-1的影响 www.ilib.cn 1. The Study on Tissue Plasminogen Activator Change in Stroke Patients 缺血性脑卒中患者血纤溶活性变化规律的研究 www.ilib.cn 2. Association of Hyperdense Middle Cerebral Artery Sign With Clinical Outcome in Patients Treated With Tissue Plasminogen Activator 中风患者高密度大脑中动脉征象与组织纤溶酶原激活剂治疗临床预后的关系 www.bhli.org.cn |
||||||||||||||||
| 随便看 |
|
英汉双解词典包含2704715条英汉词条，基本涵盖了全部常用单词的翻译及用法，是英语学习的有利工具。